Industries > Pharma > Top 20 Vaccines Manufacturers 2019

Top 20 Vaccines Manufacturers 2019

Merck & Co., Sanofi, Pfizer, GlaxoSmithKline, Johnson & Johnson, AstraZeneca, Emergent Biosolutions, Other Companies

PUBLISHED: 12 February 2019
PAGES: 157
PRODUCT CODE: PHA0355

Clear
WOOCS 2.2.1

The global vaccines market has witnessed strong growth in past few years. The top 5 manufacturers in the global vaccines market are, Merck & Co., Inc., Sanofi, Pfizer Inc., GlaxoSmithKline PLC, and Johnson & Johnson. These companies secured about 76% revenue share in the global vaccines market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you will find 157-page report and you will receive 90 tables and 75 figures – all unavailable elsewhere.

The 157-page report provides clear detailed insight into the Top 20 Vaccines Manufacturers 2019. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope
• Assessment of the leading companies in the global vaccines market:
• Astellas Pharma Inc.
• AstraZeneca
• Bavarian Nordic
• CSL Ltd.
• Emergent Biosolutions, Inc.
• F. Hoffmann-La Roche Ltd.
• Gilead Sciences
• GlaxoSmithKline PLC
• Inovio Pharmaceuticals
• Johnson & Johnson
• Merck & Co., Inc.
• Mitsubishi Tanabe Pharma Corporation
• Novavax, Inc.
• Pfizer Inc.
• Sanofi
• SELLAS Life Sciences Group, Inc.
• Serum Institute of India Pvt. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Ltd.
• Teva Pharmaceutical

Top 20 Vaccines Manufacturers 2019

This report discusses financial outlook, product portfolio and strategic developments.

• Revenues forecast from 2017-2028 for the US, Europe and Japan Vaccines Market.

Market share of key companies in the vaccines market.

Market share of leading vaccines in the global vaccines market.

Drivers, Challenges and Opportunities for the global vaccines market.

A SWOT analysis of the global vaccines market.

Visiongain’s study is intended for anyone requiring commercial analyses for the Top 20 Vaccines Manufacturers 2019. You find data, trends and predictions.

Buy our report today Top vaccine manufacturers Market Analysis : Merck & Co., Sanofi, Pfizer, GlaxoSmithKline, Johnson & Johnson, AstraZeneca, Emergent Biosolutions, Other Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Top 20 Vaccines Manufacturers 2019


Download sample pages

Complete the form below to download your free sample pages for Top 20 Vaccines Manufacturers 2019


Latest Pharma news

Visiongain Publishes Protein Labelling Reagents for Research Use Only (RUO) Market Report 2021-2031

Increasing investment in R&D for proteomics research, by both public and private organizations, is one of the major contributors to the growth of the protein labelling reagents market. The increasing prevalence of chronic diseases is also expected to contribute to the growth of this market.

05 May 2021

READ

Visiongain Publishes Aptamer Technologies Market Report 2021-2031

Over the last few years, the aptamers has gained widespread attention due to the technological advancements and growth in understanding of the oligonucleotide therapeutics that inhabit the human body.

29 April 2021

READ

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031

Rising prevalence of inflammatory bowel disease including Crohn’s disease and ulcerative colitis; raising awareness for IBD in developing countries; escalating investment in drug R&D by pharmaceutical companies; new product launches worldwide, growing chronic diseases healthcare awareness are some of the major factors that boosting the growth of global IBD drugs market.

29 April 2021

READ

Visiongain Publishes Antiviral Drugs Treatment Market Report 2021-2031

Rising incidences of viral infection; increasing geriatric population is projected to propel the demand for anti-viral drugs; advancement in anti-viral drugs R&D is driving the market growth; and rising strategic initiatives for anti-viral drugs market is another major factor propelling the market growth worldwide are some of the major factors that propel the global antiviral drugs treatment market growth.

28 April 2021

READ

Categories